30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mark Kroll

Track

Insider profile

Currently holds positions in Axon Enterprise Inc and Haemonetics Corp

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 44% 68% 82%
Transactions
9 11% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Axon Enterprise Inc Jan. 22, 2003 -
Independent Director Haemonetics Corp Jan. 1, 2006 -
Mark Kroll's trades of Haemonetics Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-12 2025-11-10
B Purchase
37,547 -22.0%
473.71
US$4,669,138 		37,547 -22.0% 473.71 US$4,669,138
2023-03-08 2023-03-07
S Sale
15,805 -42.3%
62.42
US$3,566,247 		15,805 -42.3% 62.42 US$3,566,247
2023-03-08 2023-03-07
S Sale
24,879 -35.8%
86.00
US$1,422,383 		24,879 -35.8% 86.00 US$1,422,383
2022-08-16 2022-08-15
S Sale
8,016 -33.1%
73.71
US$590,859 		8,016 -33.1% 73.71 US$590,859
2022-06-09 2022-06-08
S Sale
3,159 -18.7%
102.82
US$324,796 		3,159 -18.7% 102.82 US$324,796
2021-05-28 2021-05-26
S Sale
11,813 -39.0%
55.10
US$650,896 		11,813 -39.0% 55.10 US$650,896
2021-05-14 2021-05-12
S Sale
4,204 -23.9%
124.94
US$525,260 		4,204 -23.9% 124.94 US$525,260
2020-11-17 2020-11-16
S Sale
2,993 -13.9%
120.44
US$360,477 		2,993 -13.9% 120.44 US$360,477
2020-04-13 2020-04-09
PlS Planned sale
4,329 -19.0%
102.00
US$441,558 		4,329 -19.0% 102.00 US$441,558
2020-04-13 2020-04-09
PlS Planned sale
6,573 -22.4%
102.00
US$670,446 		6,573 -22.4% 102.00 US$670,446
2019-11-14 2019-11-13
S Sale
4,168 -17.6%
64.30
US$267,987 		4,168 -17.6% 64.30 US$267,987